0000899243-19-003843.txt : 20190215
0000899243-19-003843.hdr.sgml : 20190215
20190215160901
ACCESSION NUMBER: 0000899243-19-003843
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190215
DATE AS OF CHANGE: 20190215
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Henn Matthew R.
CENTRAL INDEX KEY: 0001767321
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37465
FILM NUMBER: 19611593
MAIL ADDRESS:
STREET 1: C/O SERES THERAPEUTICS, INC.
STREET 2: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Seres Therapeutics, Inc.
CENTRAL INDEX KEY: 0001609809
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 274326290
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617 945 9626
MAIL ADDRESS:
STREET 1: 200 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
FORMER COMPANY:
FORMER CONFORMED NAME: Seres Health, Inc.
DATE OF NAME CHANGE: 20140603
3/A
1
doc3a.xml
FORM 3/A SUBMISSION
X0206
3/A
2019-02-01
2019-02-11
0
0001609809
Seres Therapeutics, Inc.
MCRB
0001767321
Henn Matthew R.
C/O SERES THERAPEUTICS, INC.
200 SIDNEY STREET
CAMBRIDGE
MA
02139
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
0.71
2016-09-19
2024-08-06
Common Stock
26000
D
These options were inadvertently omitted from the reporting person's original Form 3 filed on February 11, 2019.
/s/ Thomas J. DesRosier, Attorney-in-fact
2019-02-15